#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial cancer recurrent Hereditary ataxia Chronic hepatitis B Acute myeloid leukaemia (in remission) Anal squamous cell carcinoma Short stature homeobox gene mutation Acute myeloid leukaemia Hypomagnesaemia Infantile spasms Liposarcoma Adrenoleukodystrophy Metachromatic leukodystrophy Hypertriglyceridaemia Liver abscess Inclusion body myositis More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Treatment Acute respiratory distress syndrome – Life with Disease Small intestine leiomyosarcoma – Basic Information Cystic fibrosis lung Fragile X syndrome – Treatment Primary biliary cholangitis – Basic Information Osteosarcoma – Treatment Ewing’s sarcoma recurrent – Basic Information Rhabdomyosarcoma recurrent – Life with Disease Waldenstrom’s macroglobulinaemia refractory – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glucocorticoids Proguanil Hydrochloride Ripretinib Rituximab ROPINIROLE HSP-CAR19M OXYBUTYNIN HYDROCHLORIDE Fazirsiran Tamsulosin Hydrochloride Ruxolitinib Soya Oil, Purified Mk-0482 Pristinamycin DAPIGLUTIDE Midostaurin Rasburicase Tolcapone Sodium Glycocholate L-SERINE Midomafetamine Hydrochloride More therapies…

    Learn about Your Condition

    Arginase deficiency Acute promyelocytic leukaemia Diabetic autonomic neuropathy Tissue anoxia Blood disorder HER2 positive gastric cancer Juvenile idiopathic arthritis Small fibre neuropathy Injection site pain Chronic spontaneous urticaria Alcohol abuse Micrographic skin surgery Fatty acid oxidation disorder Peritoneal dialysis Coagulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of MK-5684 compared to standard therapy in patients with breast cancer, ovarian cancer, or endometrial cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Ovarian cancer
    • Breast cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Hydrocortisone Acetate
    • Medroxyprogesterone Acetate
    Spain

  • Study of ONO-4578 and nivolumab with drug combination for first-line treatment in patients with PD-L1 positive advanced colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • 4-[4-CYANO-2-[[(1’R,4S)-6-(PROPAN-2-YLCARBAMOYL)SPIRO[2,3-DIHYDROCHROMENE-4,2′-CYCLOPROPANE]-1′-CARBONYL]AMINO]PHENYL]BUTANOIC ACID
    • Calcium Folinate
    • Fluorouracil
    France Italy Spain

  • Treatment with trastuzumab deruxtecan, capecitabine and bevacizumab for patients with HER2-positive metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Trastuzumab Deruxtecan
    • Bevacizumab
    France Germany Italy Spain

  • Study of SAR444336 in Adults with Microscopic Colitis Who Achieved Clinical Remission with Budesonide Treatment

    Recruiting

    2 1
    Investigated Drugs:
    • SAR444336
    Belgium Denmark France Germany Hungary Italy +2

  • Study of Gallium (68Ga) edotreotide, Fluorocholine (18F) and Fludeoxyglucose (18F) PET imaging for detection and staging of liver cancer and gastro-entero-pancreatic tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastroenteropancreatic neuroendocrine tumour disease
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Fludeoxyglucose (18F)
    France

  • Study of felzartamab compared to placebo in adults with IgA nephropathy

    Recruiting

    3 1 1
    Investigated Diseases:
    • IgA nephropathy
    Investigated Drugs:
    • Desloratadine
    • Felzartamab
    • Fexofenadine
    Belgium Bulgaria Croatia Czechia France Germany +5
Previous Page
1 … 143 144 145 146 147 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!